MASON VAN NOSTRAND: Open Payments
NPI 1588018592 · SPOKANE, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$189 in 10 payments from 6 companies in 2025. Trend: 2023 $32 · 2024 $292 · 2025 $189
Food & beverage: $189
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 3 | $57 |
| Novartis Pharmaceuticals Corporation | 3 | $48 |
| Edwards Lifesciences Corporation | 1 | $32 |
| Abbott Laboratories | 1 | $20 |
| AstraZeneca Pharmaceuticals LP | 1 | $16 |
| Amgen Inc. | 1 | $16 |
Products named: Wegovy, LEQVIO, SAPIEN 3 Ultra RESILIA, AMPLATZER TALISMAN, FARXIGA, Repatha, ENTRESTO.
Industry payments across WA — which companies pay providers there.
